Angucyclines: Biosynthesis, mode-of-action, new natural products, and synthesis

Madan K. Kharel, Pallab Pahari, Micah D. Shepherd, Nidhi Tibrewal, S. Eric Nybo, Khaled A. Shaaban, Jürgen Rohr

Research output: Contribution to journalReview articlepeer-review

276 Scopus citations

Abstract

Covering: 1997 to 2010 The angucycline group is the largest group of type II PKS-engineered natural products, rich in biological activities and chemical scaffolds. This stimulated synthetic creativity and biosynthetic inquisitiveness. The synthetic studies used five different strategies, involving Diels-Alder reactions, nucleophilic additions, electrophilic additions, transition-metal mediated cross-couplings and intramolecular cyclizations to generate the angucycline frames. Biosynthetic studies were particularly intriguing when unusual framework rearrangements by post-PKS tailoring oxidoreductases occurred, or when unusual glycosylation reactions were involved in decorating the benz[a]anthracene-derived cores. This review follows our previous reviews, which were published in 1992 and 1997, and covers new angucycline group antibiotics published between 1997 and 2010. However, in contrast to the previous reviews, the main focus of this article is on new synthetic approaches and biosynthetic investigations, most of which were published between 1997 and 2010, but go beyond, e.g. for some biosyntheses all the way back to the 1980s, to provide the necessary context of information.

Original languageEnglish
Pages (from-to)264-325
Number of pages62
JournalNatural Product Reports
Volume29
Issue number2
DOIs
StatePublished - Feb 2012

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Angucyclines: Biosynthesis, mode-of-action, new natural products, and synthesis'. Together they form a unique fingerprint.

Cite this